Tech Company Financing Transactions

Nucleonics Funding Round

Anthem Capital, Burrill & Company and Healthcap Venture Capital invested in a $6 million venture round for Nucleonics. The funding round was announced on 6/30/2005.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

13 Summit Square Center 305
Langhorne, PA 19047
USA

Phone

(866) 268-3471

Website

www.Nucleonicsinc.com

Email Address

[email protected]

Overview

Nucleonics is an emerging biotechnology company focused on the development of novel RNA interference-based therapeutics for viral and other diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Robert Towarnicki

        

Chief Financial Officer

Richard Fitzgerald

        

Chief Medical Officer

Michael Young

        

Vice President

Annette Richter

        

Browse more venture capital transactions:

Prev: 6/30/2005: Deem venture capital transaction
Next: 6/30/2005: Xtera Communications venture capital transaction

Share this article

Where The Data Comes From

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary